PRL and osteoporosis: In that study, osteoporotic conditions (low bone mineral density) were greater in prolactin‐inducing SGAs (57.1% osteoporosis, 19.0% osteopenia) and prolactin‐sparing SGAs (19.1% osteoporosis, 47.6% osteopenia) compared to no treatment (18.2% osteoporosis, 4.5% osteopenia).